Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579306 · ClinicalTrials.gov registry record
Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study
A clinical trial of Hypertension and Stroke, sponsored by Columbia University.
- Completed
- Registry status
- 1,244
- Enrollment target
- 20
- Study locations
NCT00579306: Completed study of Hypertension and Stroke, sponsored by Columbia University.
NCT00579306 is a study of Hypertension and Stroke that has completed, run by Columbia University. The registered enrollment target is 1,244 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (65% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579306, a study of Hypertension and Stroke, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 1,244 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes and who are enrolled in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.
Primary Outcome
Participants with recurrence of any stroke during follow-up, including ischemic (an acute localized ischemic lesion in the brain not attributable to central nervous system infection, tumor, demyelinating, or degenerative neurologic diseases due to an occlusive vascular disorder) and hemorrhagic (acute extravasation of blood into the parenchyma of the central nervous system or subarachnoid space).
Conditions Studied
Study Locations (20)
New York
- Columbia University Medical Center - New York
- Rochester General Hospital - Rochester
- University of Rochester Medical Center - Rochester
Arizona
- Mayo Clinic Scottsdale - Scottsdale
- University of Arizona Collage of Medicine - Tucson
California
- University of California, San Diego Medical Center - La Jolla
- Sutter Neuroscience Institute - Sacramento
Florida
- Melbourne Internal Medicine Associates - Melbourne
- University of Miami - Miami
Michigan
- Wayne State University - Detroit
- Henry Ford Health System - Detroit
Minnesota
- Hennepin County Medical Center - Minneapolis
- Mayo Clinic Rochester - Rochester
Missouri
- St. Louis University - St Louis
- St. John's Mercy Medical Center - St Louis
Alabama
- University of South Alabama - Mobile
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,244 participants |
| Start Date | 2005-06 |
| Est. Completion | 2012-07 |
What the finished NCT00579306 record still lists
NCT00579306 is an observational study that tracks outcomes without assigning an intervention. Its 1,244 participants enrollment target places it among the larger protocols in the corpus, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (65% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT00579306 names 20 study sites across 12 states, led by New York, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT00579306 about?
NCT00579306 is a clinical study titled "Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study". The goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes and who are enrolled in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.
What is the current status of trial NCT00579306?
This trial is currently completed. The enrollment target is 1,244 participants. The study started on 2005-06. Estimated completion is 2012-07.
What conditions does trial NCT00579306 study?
This clinical trial studies the following conditions: Hypertension, Stroke.
Who is sponsoring clinical trial NCT00579306?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00579306 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00579306's enrollment target sits among peer trials
1,244 55th of 470 higher than 416 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia